chrX-111730526-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001099922.3(ALG13):āc.2403G>Cā(p.Glu801Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000386 in 1,192,624 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. 2/2 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E801G) has been classified as Uncertain significance.
Frequency
Consequence
NM_001099922.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ALG13 | NM_001099922.3 | c.2403G>C | p.Glu801Asp | missense_variant, splice_region_variant | 21/27 | ENST00000394780.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ALG13 | ENST00000394780.8 | c.2403G>C | p.Glu801Asp | missense_variant, splice_region_variant | 21/27 | 2 | NM_001099922.3 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000537 AC: 6AN: 111722Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33916
GnomAD3 exomes AF: 0.0000604 AC: 9AN: 149099Hom.: 0 AF XY: 0.0000219 AC XY: 1AN XY: 45745
GnomAD4 exome AF: 0.0000370 AC: 40AN: 1080902Hom.: 0 Cov.: 29 AF XY: 0.0000370 AC XY: 13AN XY: 351148
GnomAD4 genome AF: 0.0000537 AC: 6AN: 111722Hom.: 0 Cov.: 23 AF XY: 0.0000295 AC XY: 1AN XY: 33916
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 36 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Dec 05, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 801 of the ALG13 protein (p.Glu801Asp). This variant is present in population databases (rs778396216, gnomAD 0.01%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with ALG13-related conditions. ClinVar contains an entry for this variant (Variation ID: 403876). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 18, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at